Publication:
Gut and respiratory tract microbiota in children younger than 12 months hospitalized for bronchiolitis compared with healthy children: can we predict the severity and medium-term respiratory outcome?

dc.contributor.authorCabrera-Rubio, Raul
dc.contributor.authorCalvo, Cristina
dc.contributor.authorAlcolea, Sonia
dc.contributor.authorBergia, María
dc.contributor.authorAtucha, Jorge
dc.contributor.authorPozo Sanchez, Francisco
dc.contributor.authorCasas Flecha, Inmaculada
dc.contributor.authorArroyas, María
dc.contributor.authorCollado, Maria Carmen
dc.contributor.authorGarcía-García, María Luz
dc.contributor.funderFundación Universidad Alfonso X el Sabio
dc.contributor.funderMerck, Sharp & Dohme
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderGeneralitat Valenciana (España)
dc.contributor.funderMinisterio de Ciencia e Innovación. Centro de Excelencia Severo Ochoa (España)
dc.contributor.funderMinisterio de Ciencia e Innovación (España)
dc.contributor.funderAgencia Estatal de Investigación (España)
dc.date.accessioned2025-03-17T10:39:04Z
dc.date.available2025-03-17T10:39:04Z
dc.date.issued2024-07-02
dc.descriptionThe data are publicly available from the original study: European Nucleotide Archive accession number PRJEB71847 (https://www.ebi.ac.uk/ena/browser/view/PRJEB71847).
dc.description.abstractGrowing evidence indicates that gut and respiratory microbiota have a potential key effect on bronchiolitis, mainly caused by respiratory syncytial virus (RSV). This was a prospective study of 96 infants comparing infants with bronchiolitis (n = 57, both RSV and non-RSV associated) to a control group (n = 39). Gut (feces) and respiratory [nasopharyngeal aspirate (NPA)] microbial profiles were analyzed by 16S rRNA amplicon sequencing, and respiratory viruses were identified by PCR. Clinical data of the acute episode and follow-up during the first year after infection were recorded. Pairwise comparisons showed significant differences in the gut (R2 = 0.0639, P = 0.006) and NPA (R2 = 0.0803, P = 0.006) microbiota between cases and controls. A significantly lower gut microbial richness and an increase in the NPA microbial diversity (mainly due to an increase in Haemophilus, Streptococcus, and Neisseria) were observed in the infants with bronchiolitis, in those with the most severe symptoms, and in those who subsequently developed recurrent wheezing episodes after discharge. In NPA, the higher microbial richness differed significantly between the control group and the non-RSV bronchiolitis group (P = 0.01) and between the control group and the RSV bronchiolitis group (P = 0.001). In the gut, the richness differed significantly between the control group and the non-RSV group (P = 0.01) and between the control group and the RSV bronchiolitis group (P = 0.001), with higher diversity in the RSV group. A distinct respiratory and intestinal microbial pattern was observed in infants with bronchiolitis compared with controls. The presence of RSV was a main factor for dysbiosis. Lower gut microbial richness and increased respiratory microbial diversity were associated with respiratory morbidity during follow-up. Importance: Both the intestinal and respiratory microbiota of children with bronchiolitis, especially those with respiratory syncytial virus infection, are altered and differ from that of healthy children. The microbiota pattern in the acute episode could identify those children who will later have other respiratory episodes in the first year of life. Preventive measures could be adopted for this group of infants.
dc.description.peerreviewed
dc.description.sponsorshipThis study was partially funded by X Convocatoria proyectos de investigación, Fundación UAX. 2018, Grant SEICAP: Convocatoria de Becas de Investigación SEICAP, Curso 2018-19, Grant SENP 2018 (Beca Senior de Investigación), Grant SEPAR 2020, Ayuda a la investigación categoría de neumología pediátrica,. Investigator Studies Program (MISP) Merck Sharp & Dohme Corp. The opinions correspond to the investigators and do not necessarily represent MSD. Funding was provided by FIS (Fondo de Investigaciones Sanitarias)–Spanish Health Research Fund-FONDOS FEDER Grants: PI18CIII/00009 and PI18/00167; PI21/00377. R.C.-R. thanks Generalitat-Valenciana (GVA) for the grant Plan GenT-Talent Attraction program (CDEIGENT 2020). M.C.C. would like to acknowledge the support from the Spanish Ministry of Science and Innovation (MCIN) research grant (ref. PID2022-139475OB-I00) and also from PROMETEO-GVA grant for Excellence Research Groups (NEOHEALTH ref.012/2020). M.C.C. and R.C.-R. would also acknowledge the award of the Spanish Government MCIN/AEI to the Institute of Agrochemistry and Food Technology (IATA-CSIC) as Centre of Excellence Severo Ochoa (CEX2021-001189-S MCIN/AEI/10.13039/501100011033).
dc.format.number7
dc.format.pagee0255623
dc.format.volume12
dc.identifier.citationCabrera-Rubio R, Calvo C, Alcolea S, Bergia M, Atucha J, Pozo F, Casas I, Arroyas M, Collado MC, García-García ML. Gut and respiratory tract microbiota in children younger than 12 months hospitalized for bronchiolitis compared with healthy children: can we predict the severity and medium-term respiratory outcome? Microbiol Spectr. 2024 Jul 2;12(7):e0255623.
dc.identifier.doi10.1128/spectrum.02556-23
dc.identifier.e-issn2165-0497
dc.identifier.journalMicrobiology spectrum
dc.identifier.pubmedID38785596
dc.identifier.urihttps://hdl.handle.net/20.500.12105/26492
dc.language.isoeng
dc.publisherAmerican Society for Microbiology (ASM)
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI18CIII/00009
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI18/00167
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI21/00377
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/CEX2021-001189-S
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PID2022-139475OB-I00
dc.relation.publisherversionhttps://doi.org/10.1128/spectrum.02556-23
dc.repisalud.centroISCIII::Centro Nacional de Microbiología (CNM)
dc.repisalud.institucionISCIII
dc.repisalud.instituteIIS::IdiPAZ - Instituto de Investigación Sanitaria Hospital La Paz (Madrid)
dc.repisalud.instituteIIS::IDIPHIM - Instituto de Investigación Sanitaria Puerta de Hierro (Madrid)
dc.rights.accessRightsopen access
dc.rights.licenseAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectGut microbiota
dc.subjectInfants
dc.subjectNasopharyngeal microbiota
dc.subjectRespiratory syncytial virus
dc.subjectVirus
dc.subject.meshBacteria
dc.subject.meshBronchiolitis
dc.subject.meshFeces
dc.subject.meshFemale
dc.subject.meshGastrointestinal Microbiome
dc.subject.meshHospitalization
dc.subject.meshHumans
dc.subject.meshInfant
dc.subject.meshInfant, Newborn
dc.subject.meshMale
dc.subject.meshMicrobiota
dc.subject.meshNasopharynx
dc.subject.meshProspective Studies
dc.subject.meshRNA, Ribosomal, 16S
dc.subject.meshRespiratory Syncytial Virus Infections
dc.subject.meshRespiratory System
dc.subject.meshSeverity of Illness Index
dc.titleGut and respiratory tract microbiota in children younger than 12 months hospitalized for bronchiolitis compared with healthy children: can we predict the severity and medium-term respiratory outcome?
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isAuthorOfPublication5611ffc3-de88-4908-b20a-9a15a58c060a
relation.isAuthorOfPublicatione2df6e55-f1d3-423b-a72f-fd9a69cf5915
relation.isAuthorOfPublication.latestForDiscovery5611ffc3-de88-4908-b20a-9a15a58c060a
relation.isFunderOfPublicationa6ae0db5-9c7b-4544-b685-008673740ac3
relation.isFunderOfPublication0af19d44-b1aa-474e-9aaa-28c40dc292b3
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublication842e6617-7822-4501-a927-7e8cedda4aa6
relation.isFunderOfPublication9bec53f6-b1d2-4340-9f6b-91815956d602
relation.isFunderOfPublication289dce42-6a28-4892-b0a8-c70c46cbb185
relation.isFunderOfPublication54733407-1d78-4c44-bf4c-8c8a7592aa4b
relation.isFunderOfPublication.latestForDiscoverya6ae0db5-9c7b-4544-b685-008673740ac3
relation.isPublisherOfPublication30cd8aef-e018-40d1-b05e-19af778995bd
relation.isPublisherOfPublication.latestForDiscovery30cd8aef-e018-40d1-b05e-19af778995bd

Files

Original bundle

Now showing 1 - 4 of 4
Loading...
Thumbnail Image
Name:
GutRespiratoryTractMicrobiota_2024.pdf
Size:
1.9 MB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
Supplementary_TS1_GutRespiratoryTractMicrobiota_2024.pdf
Size:
413.07 KB
Format:
Adobe Portable Document Format
Description:
Table S1 - FSO with the significant variables in NPA and gut samples.
Loading...
Thumbnail Image
Name:
Supplementary_TS2_GutRespiratoryTractMicrobiota_2024.pdf
Size:
428.09 KB
Format:
Adobe Portable Document Format
Description:
Table S2 - Test of the difference in environmental variables across groups with the cal_diff function.
Loading...
Thumbnail Image
Name:
Supplementary_TS3_GutRespiratoryTractMicrobiota_2024.pdf
Size:
181.76 KB
Format:
Adobe Portable Document Format
Description:
Table S3 - Viral detection.